SCHEMBL1948713

SCHEMBL1948713

[CH2]CCCCCCCCCCCCCCCN

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 0.61
CA12 O43570 2/20 0.61
CA1 P00915 2/20 0.61
CA2 P00918 2/20 0.61
CA3 P07451 2/20 0.61
CA4 P22748 2/20 0.61
CA6 P23280 2/20 0.61
CA5A P35218 2/20 0.61
CA7 P43166 2/20 0.61
CA9 Q16790 2/20 0.61
CA14 Q9ULX7 2/20 0.61
CA5B Q9Y2D0 2/20 0.61
TSHR P16473 2/20 0.61
LMNA P02545 1/20 0.61
BLM P54132 1/20 0.61
NFKB1 P19838 1/20 0.54
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.44
EPHX1 P07099 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233534 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL3054555 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL5085490 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL2796068 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL2031871 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL4755739 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL4755756 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL4754026 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL2796425 1.00 DNM1 (0.61) DNM1CA12CA1CA2CA3
SCHEMBL233652 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110577557-A sialic acid lipid derivative and preparation method and application thereof 沈阳药科大学 2019-12-17 CN claimed
CN-107074923-A APOE simulating peptides and the more efficient power to removing plasma cholesterol UAB研究基金会 2017-08-18 CN claimed
CN-110577557-B Sialic acid lipid derivative and preparation method and application thereof 沈阳药科大学 2022-03-11 CN disclosed
US-10758492-B2 Two-dimensional polymeric structures and method for producing thereof Ecole polytechnique fédérale de Lausanne (EPFL) (CH) 2020-09-01 US disclosed
CN-110577557-A sialic acid lipid derivative and preparation method and application thereof 沈阳药科大学 2019-12-17 CN disclosed
US-20170258737-A1 TWO-DIMENSIONAL POLYMERIC STRUCTURES AND METHOD FOR PRODUCING THEREOF Ecole polytechnique fédérale de Lausanne (EPFL) (CH) 2017-09-14 US disclosed
CN-107074923-A APOE simulating peptides and the more efficient power to removing plasma cholesterol UAB研究基金会 2017-08-18 CN disclosed
EP-3193846-A1 TWO-DIMENSIONAL POLYMERIC STRUCTURES AND METHOD FOR PRODUCING THEREOF Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) 2017-07-26 EP disclosed
WO-2016042484-A1 TWO-DIMENSIONAL POLYMERIC STRUCTURES AND METHOD FOR PRODUCING THEREOF ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2016-03-24 WO disclosed
US-9107814-B2 Micelle composition of polymer and passenger drug WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-08-18 US disclosed
US-8551999-B2 Heterocyclic compound and pharmaceutical composition thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-10-08 US disclosed
US-6949281-B1 Varnish composition and liquid-crystal display element CHISSO CORPORATION (JP) 2005-09-27 US disclosed
US-6403826-B1 SALTS OF AMINOPHOSPHONIC ACIDS OR AMINOPHOSPHOROUS ACIDS WITH ZIRCONIUM, BISMUTH, CALCIUM OR CERTAIN AMINES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-11 US disclosed
US-6160164-A Corrosion-inhibiting coating composition for metals CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-12-12 US disclosed
US-5980619-A INHIBITING OR ELIMINATING METAL CORROSION CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-11-09 US disclosed
EP-0143385-B1 PHOSPHORYLISED GLYCOSIL AMIDES, UREAS, CARBAMATES AND THIOCARBAMATES, METHOD FOR THEIR PREPARATION AND THEIR USE BAYER AG (DE) 1989-03-15 EP disclosed
US-4686208-A Phosphorylated glycosyl-amides, -ureas, -carbamates and -thiocarbamates and method of use BAYER AKTIENGESELLSCHAFT (DE) 1987-08-11 US disclosed
US-4631272-A N-acylated 1-alkylamino-1-deoxy-ketose derivatives, a process for their preparation and their use BAYER AKTIENGESELLSCHAFT (DE) 1986-12-23 US disclosed
EP-0152856-A2 N-acylated 1-alkylamimo-1-desoxy ketose derivatives, method for their preparation and use BAYER AG (DE) 1985-08-28 EP disclosed
EP-0143385-A2 Phosphorylised glycosil amides, ureas, carbamates and thiocarbamates, method for their preparation and their use BAYER AG (DE) 1985-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170258737-A1 TWO-DIMENSIONAL POLYMERIC STRUCTURES AND METHOD FOR PRODUCING THEREOF MLEC, EPCAM, VIM DNM1 4702/4885CA12 398/4885CA1 1423/4885
US-10758492-B2 Two-dimensional polymeric structures and method for producing thereof MLEC, EPCAM, VIM DNM1 4702/4885CA12 398/4885CA1 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.